Global TB control – progress, challenges and a path for the Pacific
![Ben Marais, Mikaela Coleman and the PEARL study Medical Lead Jeremy Hill Ben Marais, Mikaela Coleman and the PEARL study Medical Lead Jeremy Hill](/sites/default/files/styles/event_main/public/Ben%20Marais%2C%20Mikaela%20Coleman%20and%20the%20PEARL%20study%20Medical%20Lead%20Jeremy%20Hill.jpg?itok=9VwuMOHW)
This presentation will explore challenges and pathways for global TB control, focusing on genomic insights into TB evolution, lessons learned from drug-resistant Mtb transmission and an evaluation of the merits and utility of active case finding. We then describe a population-wide active case finding study in the Pacific (the PEARL study), seeking to apply some highlighted TB control strategies with preliminary findings.
Speakers
Ben Marais
Ben is Acting-Director of the Sydney Infectious Diseases Institute (Sydney ID) and WHO Collaborating Centre in Tuberculosis at the University of Sydney. He is a Paediatric Infectious Diseases specialist at The Children's Hospital Westmead and leads a population-wide tuberculosis and leprosy systematic test&treat implementation study in the Pacific Island Nation of Kiribati (the PEARL study).
Mikaela Coleman
Mikaela is a post-doctoral fellow and PEARL study coordinator, She has a PhD in TB immunology and degrees in Public Health & Law.
Admission
Contact
![TB Centre logo](/sites/default/files/styles/event_logos/public/tbcentre.jpg?itok=75ehxo1w)